Skip to content
Men Under Microscope – Lifestyle
Home
Sample Page
Author:
Virax BioLabs Group Limited
Virax Biolabs Group Limited Announces 1-for-25 Share Consolidation
June 24, 2026
Virax Biolabs Reports Positive Early Clinical Data for ViraxImmune™ in Long COVID and Related Post-Acute Infection Syndromes
May 26, 2026
Virax Biolabs’ CEO James Foster Outlines Strategic Priorities and Near-Term Milestones in Letter to Shareholders
April 14, 2026
Virax Biolabs Achieves ISO Certifications, Laying Foundation for Regulated IVD Development and U.S. Clinical Validation
March 31, 2026